Asarfi Hospital Limited (BOM:543943)
India · Delayed Price · Currency is INR 229.30
-0.45 (-0.20%)
At close: Jun 17, 2026
Asarfi Hospital Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,735 | 1,206 | 844 | 707.03 | 652.13 | |
Revenue Growth (YoY) | 43.91% | 42.85% | 19.37% | 8.42% | 20.49% |
Cost of Revenue | 652.76 | 469.27 | 350.23 | 339.25 | 357.44 |
Gross Profit | 1,082 | 736.38 | 493.78 | 367.79 | 294.69 |
Selling, General & Admin | - | 28.58 | 25.3 | 17.42 | 11.47 |
Other Operating Expenses | 729.5 | 472.33 | 307.82 | 212.65 | 175.36 |
Operating Expenses | 844.92 | 627.66 | 421 | 268.8 | 220.3 |
Operating Income | 237.36 | 108.72 | 72.78 | 98.99 | 74.39 |
Interest Expense | -42.44 | -40.37 | -22.79 | -8.67 | -2.31 |
Interest & Investment Income | - | 12.08 | 7.03 | 2.18 | 2.94 |
Other Non Operating Income (Expenses) | 27.02 | 26.32 | 5.4 | 16.38 | 2.15 |
EBT Excluding Unusual Items | 221.94 | 106.75 | 62.41 | 108.89 | 77.17 |
Gain (Loss) on Sale of Assets | - | 3.98 | - | - | - |
Other Unusual Items | - | 32.38 | - | - | - |
Pretax Income | 221.94 | 143.11 | 62.41 | 108.89 | 77.17 |
Income Tax Expense | 55.33 | 37.35 | 20.8 | 28.73 | 19.88 |
Net Income | 166.61 | 105.76 | 41.62 | 80.15 | 57.28 |
Preferred Dividends & Other Adjustments | - | -0 | - | - | - |
Net Income to Common | 166.61 | 105.76 | 41.62 | 80.15 | 57.28 |
Net Income Growth | 57.53% | 154.13% | -48.08% | 39.92% | 62.08% |
Shares Outstanding (Basic) | 20 | 20 | 18 | 11 | 7 |
Shares Outstanding (Diluted) | 20 | 20 | 18 | 11 | 7 |
Shares Change (YoY) | -0.03% | 9.02% | 70.59% | 41.13% | - |
EPS (Basic) | 8.47 | 5.37 | 2.31 | 7.58 | 7.64 |
EPS (Diluted) | 8.47 | 5.37 | 2.31 | 7.58 | 7.64 |
EPS Growth | 57.73% | 132.91% | -69.56% | -0.84% | 62.21% |
Free Cash Flow | 1.95 | -161.37 | -200 | -222.06 | -102.53 |
Free Cash Flow Per Share | 0.10 | -8.20 | -11.08 | -20.99 | -13.68 |
Gross Margin | 62.38% | 61.08% | 58.50% | 52.02% | 45.19% |
Operating Margin | 13.68% | 9.02% | 8.62% | 14.00% | 11.41% |
Profit Margin | 9.60% | 8.77% | 4.93% | 11.34% | 8.78% |
Free Cash Flow Margin | 0.11% | -13.38% | -23.70% | -31.41% | -15.72% |
EBITDA | 352.78 | 235.48 | 160.66 | 137.73 | 107.86 |
EBITDA Margin | 20.33% | 19.53% | 19.04% | 19.48% | 16.54% |
D&A For EBITDA | 115.42 | 126.76 | 87.88 | 38.74 | 33.47 |
EBIT | 237.36 | 108.72 | 72.78 | 98.99 | 74.39 |
EBIT Margin | 13.68% | 9.02% | 8.62% | 14.00% | 11.41% |
Effective Tax Rate | 24.93% | 26.10% | 33.32% | 26.39% | 25.77% |
Revenue as Reported | 1,762 | 1,281 | 860.71 | 730.33 | 661.95 |
Advertising Expenses | - | 8.15 | 5.98 | 17.31 | 11.12 |